POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer
Oncology Reports · 11.03.2026 · 55 (5) · 1-14
DOI: 10.3892/or.2026.9097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, online erschienen am 11.03.2026. Verfasst von Ningning Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Nankai University, Tianjin 300071, P.R. China. Hauptthemen laut MEDLINE: DNA Polymerase theta, Immune Tolerance, Ataxia Telangiectasia Mutated Proteins, Tumor Suppressor Protein p53. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Nankai University, Tianjin 300071, P.R. China.
- Department of Pediatrics, Affiliated Taihe Hospital of Hubei University of Medicine, Shiyan, Hubei 442000, P.R. China.
- Department of Esophageal Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, P.R. China.
Zitieren
APA
Zhu, N., Wang, J., Zhang, X., Tang, K., Gong, L., & Hu, Y. (2026). POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer. Oncology Reports, 55(5), 1-14. https://doi.org/10.3892/or.2026.9097
Vancouver
Zhu N, Wang J, Zhang X, Tang K, Gong L, Hu Y. POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer. Oncology Reports. 2026;55(5):1-14. doi:10.3892/or.2026.9097
BibTeX
@article{Zhu2026,
author = {Zhu, Ningning and Wang, Juanjuan and Zhang, Xiaoli and Tang, Kai and Gong, Lei and Hu, Yi},
title = {POLQ promotes tumor progression and immunosuppression via ATM‑P53 signaling in endometrial cancer},
journal = {Oncology Reports},
year = {2026},
volume = {55},
number = {5},
pages = {1--14},
doi = {10.3892/or.2026.9097}
}
EUVIMED